Cargando…
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers
Immunotherapy utilizing induced pluripotent stem cell (iPSC) technology has great potential. Functionally rejuvenated cytotoxic T lymphocytes (CTLs) can survive long-term as young memory T cells in vivo, with continuous tumor eradication. Banking of iPSCs as an unlimited “off-the-shelf” source of th...
Autores principales: | Honda, Tadahiro, Ando, Miki, Ando, Jun, Ishii, Midori, Sakiyama, Yumi, Ohara, Kazuo, Toyota, Tokuko, Ohtaka, Manami, Masuda, Ayako, Terao, Yasuhisa, Nakanishi, Mahito, Nakauchi, Hiromitsu, Komatsu, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646217/ https://www.ncbi.nlm.nih.gov/pubmed/32710827 http://dx.doi.org/10.1016/j.ymthe.2020.07.004 |
Ejemplares similares
-
An assessment of the effects of ectopic gp91phox expression in XCGD iPSC-derived neutrophils
por: Lin, Huan-Ting, et al.
Publicado: (2015) -
Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells in vivo
por: Ando, Miki, et al.
Publicado: (2020) -
A Safeguard System for Induced Pluripotent Stem Cell-Derived Rejuvenated T Cell Therapy
por: Ando, Miki, et al.
Publicado: (2015) -
High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells
por: Nagano, Seiji, et al.
Publicado: (2019) -
Advances in Allogeneic Cancer Cell Therapy and Future Perspectives on “Off-the-Shelf” T Cell Therapy Using iPSC Technology and Gene Editing
por: Furukawa, Yoshiki, et al.
Publicado: (2022)